Latuda
Latuda (lurasidone) is an atypical antipsychotic medication. It is believed to work by modulating the activity of dopamine and serotonin receptors in the brain, helping to manage symptoms of schizophrenia and bipolar depression. It must be taken with food (at least 350 calories) for proper absorption.
Dosage by Body Weight
Always take Latuda with food (a meal or snack of at least 350 calories). The starting dose for schizophrenia in adults is typically 40 mg once daily, with a maximum dose of 160 mg daily. For bipolar depression, the starting dose is typically 20 mg once daily, with a maximum dose of 120 mg daily. Dosage adjustments are required for patients with moderate to severe renal or hepatic impairment.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in patients in this pediatric population.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in patients in this pediatric population.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in patients in this pediatric population.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric patients under 10 years of age.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established for children under 10 years of age; pediatric dosing for older children (10+ years) is determined by clinical response, not strictly by body weight.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and efficacy have not been established in patients in this pediatric population. |
| 5-7 kg | Not recommended | N/A | Safety and efficacy have not been established in patients in this pediatric population. |
| 8-10 kg | Not recommended | N/A | Safety and efficacy have not been established in patients in this pediatric population. |
| 11-15 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric patients under 10 years of age. |
| 16-20 kg | Not recommended | N/A | Safety and efficacy have not been established for children under 10 years of age; pediatric dosing for older children (10+ years) is determined by clinical response, not strictly by body weight. |
Formulation
Purpose
Treatment of schizophrenia in adults and adolescents aged 13-17 years. Also used for the treatment of depressive episodes associated with Bipolar I Disorder (bipolar depression) in adults and pediatric patients aged 10-17 years, either as monotherapy or as adjunctive therapy with lithium or valproate.
Generic Name
Lurasidone HydrochlorideScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.